Website Search
In a previous post we noted the increasing importance of biologics as therapeutic agents, with 37% of the drugs approved by the FDA in 2017 being biologic entities. A recent article in Chemical & ...
Presenter: Rebecca Laborde, PhD.
Field Application Scientist, Regional Marketing ...
The cost of drug production has soared into the billions, presenting a huge barrier to companies hoping to market new medicines and creating a pressing need for more efficient development techniques.
Translational Medicine Informatics requires managing clinical, biobank, and research data in an integrated ...
Translational Medicine is developing into a key enabling suite of data-rich technologies that is transforming ...
Originally presented at Bio-IT World April 10, 2013